ALTHE logo

Theraclion SA Stock Price

ENXTPA:ALTHE Community·€32.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

ALTHE Share Price Performance

€0.69
0.34 (96.01%)
€0.69
0.34 (96.01%)
Price €0.69

ALTHE Community Narratives

There are no narratives available yet.

Snowflake Analysis

Moderate risk with weak fundamentals.

5 Risks
0 Rewards

Theraclion SA Key Details

€830.2k

Revenue

€4.7m

Cost of Revenue

-€3.8m

Gross Profit

€1.9m

Other Expenses

-€5.8m

Earnings

Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
-0.12
-460.89%
-693.45%
-6,651,015.8%
View Full Analysis

About ALTHE

Founded
2004
Employees
32
CEO
Martin Deterre
WebsiteView website
www.theraclion.com

Theraclion SA provides therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient’s skin and optimize image quality. The company was incorporated in 2004 and is headquartered in Malakoff, France.

Recent ALTHE News & Updates

Recent updates

No updates